# FDA Inspection 1173041 - Hiers Enterprises, LLC dba Northwest Compounding Pharmacy - June 16, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/hiers-enterprises-llc-dba-northwest-compounding-pharmacy/46f40b15-29ec-42ec-b352-105ae426558d
Source feed: FDA_Inspections

> FDA Inspection 1173041 for Hiers Enterprises, LLC dba Northwest Compounding Pharmacy on June 16, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1173041
- Company Name: Hiers Enterprises, LLC dba Northwest Compounding Pharmacy
- Inspection Date: 2022-06-16
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1157204 - 2021-11-10](https://www.globalkeysolutions.net/records/fda_inspections/hiers-enterprises-llc-dba-northwest-compounding-pharmacy/f450e145-da59-40fd-beff-1e596359e90a)

Company: https://www.globalkeysolutions.net/companies/hiers-enterprises-llc-dba-northwest-compounding-pharmacy/d97cbd91-b7d4-4499-886c-3d9a76efd049

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c